| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| J. E. Davis | CEO and President | 2026-06-01 | 10,000 | $194.14 | $1.94MSell |
| Mark E. Delaney | SVP Chief Commercial Officer | 2026-04-20 | 37 | $194.70 | $7.20kBuy |
| Karthik Kuppusamy | SVP Clinical Solutions | 2026-04-20 | 39 | $194.70 | $7.59kBuy |
| Vicky B. Gregg | Director | 2026-04-20 | 68 | $194.70 | $13.24kBuy |
| Robert B. Carter | Director | 2026-04-20 | 7 | $194.70 | $1.36kBuy |
| Wright Lassiter Iii | Director | 2026-04-20 | 6 | $194.70 | $1.17kBuy |
| Patrick Plewman | SVP for Diagnostic Services | 2026-04-20 | 49 | $194.70 | $9.54kBuy |
| Sam Samad | Executive Vice President CFO | 2026-04-20 | 108 | $194.70 | $21.03kBuy |
| Catherine T. Doherty | EVP Regional Businesses | 2026-03-05 | 5,558 | $206.21 | $1.15MSell |
| Patrick Plewman | SVP for Diagnostic Services | 2026-03-05 | 2,855 | $206.21 | $588.73kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc | 8.29% | 9,172,292 | $1.84B | Institution |
| Vanguard Capital Management LLC | 6.46% | 7,145,672 | $1.43B | Institution |
| Price T Rowe Associates Inc | 5.69% | 6,297,987 | $1.26B | Institution |
| Vanguard Portfolio Management LLC | 5.49% | 6,081,400 | $1.22B | Institution |
| State Street Corp | 4.86% | 5,380,821 | $1.08B | Institution |
| Boston Partners | 3.62% | 4,012,232 | $803.61M | Institution |
| Jpmorgan Chase Co | 3.47% | 3,846,456 | $770.41M | Institution |
| Geode Capital Management LLC | 2.79% | 3,086,308 | $618.16M | Institution |
| Morgan Stanley | 2.24% | 2,479,720 | $496.66M | Institution |
| Edgepoint Investment Group Inc | 2.03% | 2,243,869 | $449.42M | Institution |